コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 RNase A can be made toxic to cancer cells by replacing G
2 RNase A has a thermal pretransition near 320 K.
3 RNase A is a far more efficient catalyst of RNA cleavage
4 RNase A is so resistant to urea denaturation at pH* 6.35
5 RNase A is the prototype of an extensive family of diver
6 RNase A treatment of cellular chromatin released a fract
7 RNase A variants and homologues, such as G88R RNase A, t
8 RNase A, a model protein for oxidative folding studies,
9 RNase A-2, the more cationic (pI 11.0), is both angiogen
10 es [30-75] is similar to that of des [40-95] RNase A, in that des [30-75] ONC is also a disulfide-sec
11 ng of both bovine pancreatic ribonuclease A (RNase A) and a 58-72 fragment thereof from the fully red
13 ovalent interactions between ribonuclease A (RNase A) and cytidylic acid ligands (2'-CMP, CTP), a wel
18 at divalent anion binding to ribonuclease A (RNase A) contributes to RNase A folding and stability.
19 ferent schemes to immobilize ribonuclease A (RNase A) in either a preferred orientation or random ori
21 enin (hANG), a member of the ribonuclease A (RNase A) superfamily known to be involved in neovascular
22 onally varied members of the ribonuclease A (RNase A) superfamily provide an excellent opportunity to
23 ber of the bovine pancreatic ribonuclease A (RNase A) superfamily, is in phase III clinical trials as
24 , a protein belonging to the ribonuclease A (RNase A) superfamily, which has recently been found to h
26 lations of bovine pancreatic ribonuclease A (RNase A) up to its melting temperature (Tm approximately
28 ppAp) with bovine pancreatic ribonuclease A (RNase A) was characterized by calorimetry and solution N
29 on of enzymatic product from ribonuclease A (RNase A) was investigated by creation of a chimeric enzy
30 single-turnover kinetics of ribonuclease A (RNase A) was measured with better than millisecond resol
31 d-type mice generated CML on ribonuclease A (RNase A), a model protein, by a pathway that required L-
32 th that of the parent enzyme ribonuclease A (RNase A), and a model was devised to assess the importan
34 conase (ONC), a homologue of ribonuclease A (RNase A), is in clinical trials for the treatment of can
39 ering hyaluronic acid (HA)-modified RNase A (RNase A-HA) in nanocomplex with cationic lipid-like mole
41 ) is a potent inducer of angiogenesis and an RNase A homologue whose ribonucleolytic activity is esse
44 ents, did not differ between apo RNase A and RNase A/pTppAp indicating that backbone dynamics contrib
47 of paromomycin binding on both RNase H- and RNase A-mediated cleavage of the RNA strand in the DNA.R
49 ipitation of hnRNPK and XRN2 from intact and RNase A-treated nuclear extracts followed by shotgun mas
51 ces in the folding mechanism between ONC and RNase A are attributed to the differences in their amino
53 proteins of the ribonuclease family, ONC and RNase A, which have similar three-dimensional folds but
54 urifies with RNA as an inactive protein, and RNase A treatment enables strong DNA deaminase activity.
55 ucture of the complex between porcine RI and RNase A. hRI, which is anionic, also appears to use its
56 extent human pancreatic RNase (hPR), another RNase A superfamily member, activates human dendritic ce
58 Structure analysis of the original antibody-RNase A complex suggested peripheral interface residues
59 ics measurements, did not differ between apo RNase A and RNase A/pTppAp indicating that backbone dyna
60 elaxation studies were performed on both apo RNase A and RNase A/pTppAp as a function of temperature.
62 ntrast, the non-covalent interaction between RNase A and RI is one of the strongest known, with the R
68 aracteristics of aqueous solutions of bovine RNase A in the presence of 100 mM KCl and 10 mM Bis-Tris
69 inual comparisons of human RNase 1 to bovine RNase A, an enzyme that appears to function primarily in
70 hysicochemical constraints upon catalysis by RNase A, the effects of salt concentration, pH, solvent
72 indicates that catalysis of RNA cleavage by RNase A is limited by the rate of substrate association,
73 NA in the VSV nucleocapsid can be removed by RNase A, in contrast to what was previously reported.
81 ogether, this work characterizes a divergent RNase A ribonuclease with a unique expression pattern an
83 deliver payloads of cytotoxic protein (i.e., RNase A) to the cells without a loss in its biological f
84 like fibril of the well-characterized enzyme RNase A contains native-like molecules capable of enzyma
85 ogues of the pancreatic ribonuclease family: RNase A and eosinophil cationic protein (or RNase 3).
86 on and function of RNase 7, one of the final RNase A superfamily ribonucleases identified in the huma
88 Using DEF-RNase A rather than fluorescein-RNase A in a microplate assay at pH 7.12 increased the Z
90 ameters, S(2), were significantly higher for RNase A/pTppAp than for the apo enzyme indicating a decr
91 roup, and nonbridging phosphoryl oxygens for RNase A to values observed for hydronium- or hydroxide-c
94 (Thr35, Asp67, and Phe98) are conserved from RNase A and serve to generate a similar bell-shaped pH v
96 s comparing unmodified peptides derived from RNase A and BID BH3 with various i,i+4 and i,i+7 stapled
97 reatic ribonuclease B (RNase B) differs from RNase A by the presence of an oligosaccharide moiety cov
98 ptide constructs based on the C peptide from RNase A, the conformational entropy is calculated versus
100 Nase A variants and homologues, such as G88R RNase A, that retain ribonucleolytic activity in the pre
102 complex of RI with fluorescein-labeled G88R RNase A was determined to be (7.5 +/- 0.4) x 10(-3) s(-1
103 A is nearly 10-fold more cytotoxic than G88R RNase A and has more than 10-fold less affinity for RI.
105 in the reductive unfolding of the homologue, RNase A, there are two intermediates, arising from the r
106 d conformational changes are not observed if RNase A is allowed to equilibrate under denaturing condi
110 istidine residues (His12, -105, and -119) in RNase A were successfully determined by this method and
111 esidues around the (40-95) disulfide bond in RNase A, which is analogous to the (30-75) disulfide bon
112 m the (40-95) and (65-72) disulfide bonds in RNase A and the fourfold more exposed cysteine sulfur at
113 ents were used to compare mus-ms dynamics in RNase A in the apo form and as complexed to the substrat
115 indicating the importance of flexibility in RNase A in the overall rate-limiting product release ste
116 curves show that the time scale of motion in RNase A is unchanged when pTppAp binds and is similar to
119 er, a comparison of the critical residues in RNase A and human angiogenin, which share only 35% amino
121 However, 28 of the amino acid residues in RNase A were identified as undergoing chemical exchange
127 for two protein-ligand binding interactions (RNase A + cytidine 2'-monophosphate and streptavidin + b
129 hil ribonuclease cluster, and the only known RNase A ribonuclease expressed specifically in response
131 omatography-mass spectrometry (LC-MS) to map RNase A and T1 digestion products onto the tRNA, and use
132 his delivering hyaluronic acid (HA)-modified RNase A (RNase A-HA) in nanocomplex with cationic lipid-
133 results suggest that brain ribonuclease, not RNase A, is the true bovine homolog of human RNase 1, an
134 acids 71-76) and III (amino acids 89-104) of RNase A-2 are both important for bactericidal activity.
135 reveal that the side-chain of tyrosine 92 of RNase A, a highly conserved residue among mammalian panc
136 and HIV-1 Gag in the presence and absence of RNase A indicated that the two proteins do not interact
140 revious studies showed that tight binding of RNase A and angiogenin (Ang) is achieved primarily throu
147 olarized cells have diminished expression of RNase A superfamily proteins, and we report for the firs
149 ] disulfide bond in the oxidative folding of RNase A, use has been made of [C65S, C72S], a three-disu
152 propensity of the unfolded reduced forms of RNase A to form the native set of disulfides directly, c
156 ls than is any known variant or homologue of RNase A including Onconase, an amphibian homologue in ph
160 Thus, OVS is both a useful inhibitor of RNase A and a potential bane to chemists and biochemists
162 ng-lived disulfide-insecure intermediates of RNase A, and oxidize them directly under stable conditio
165 cells, and the resulting different levels of RNase A-NBC reactivation, RNase A-NBC shows a significan
167 n-permeabilized oocytes or microinjection of RNase A into the oocyte released essentially all of the
170 72S], a three-disulfide-containing mutant of RNase A which regenerates from its two-disulfide precurs
171 er, the construction of a septuple mutant of RNase A, retaining a single cysteine residue, demonstrat
172 lding events in single-tryptophan mutants of RNase A were investigated by fluorescence measurements b
175 de bonds on the oxidative folding pathway of RNase A; it also facilitated the isolation of des [58-11
177 romatic thiols increased the folding rate of RNase A by a factor of 10-23 over that observed for glut
180 ions representing the free energy surface of RNase A using chemical shifts as replica-averaged restra
185 tween 1.7 and 1.3 times faster than those of RNase A at the temperatures that were investigated.
186 B were determined to be similar to those of RNase A in that two structured intermediates, each lacki
193 erize complexes of RI with a wide variety of RNase A variants and homologues, including those with cy
196 kb on chromosome 6, the coding sequences of RNases A-1 and A-2 are diverging under positive selectio
198 together, hydrogen exchange (HX) studies on RNase A at pH* 6.35 were used to investigate the basic t
200 , recombinant angiogenin, but not RNase 4 or RNase A, induces tiRNA production and inhibits protein s
201 oriented RNase A over the randomly oriented RNase A was also apparent in the orientational behavior
202 The higher binding ability of the oriented RNase A over the randomly oriented RNase A was also appa
203 adopts the same fold as angiogenin and other RNase A paralogs, but the toxin does not share sequence
208 titution increased the K(d) value of the pRI.RNase A complex by 20 x 10(6)-fold (to 1.4 microM) with
209 mple a reaction system involving the protein RNase A, its inhibitor CMP, the osmolyte urea, and water
210 compare the unfolding profiles of a protein (RNase A) and a glycoprotein (RNase B) as measured by Ram
211 of macromolecular damage, effecting protein (RNase A) photocross-linking and peptide (melittin) photo
212 cal approach to reversibly modulate protein (RNase A) function and develop a protein that is responsi
213 ed RNase L, viral RNAs cleaved with purified RNase A and RNA from uninfected and poliovirus-infected
215 red protein, fully reduced ribonuclease A (r-RNase A), have been measured using synchrotron-based sma
216 ifferent levels of RNase A-NBC reactivation, RNase A-NBC shows a significant specific cytotoxicity ag
217 ium conformational ensemble of fully reduced RNase A resembles the transient conformational ensemble
219 volution and function of two closely related RNase A ribonucleases from the chicken, Gallus gallus.
220 nt a detailed study of functionally relevant RNase A dynamics in the wild type and a D121A mutant for
221 are replicated; the correspondence to the RI-RNase A complex is somewhat greater, but still modest.
222 I is one of the strongest known, with the RI.RNase A complex having a K(d) value in the femtomolar ra
223 regions in the molecular interface of the RI.RNase A complex that exhibit a high degree of geometric
224 the genes of bovine pancreatic ribonuclease (RNase A) and human angiogenin, and a genetic selection b
226 mbers of the bovine pancreatic ribonuclease (RNase A) superfamily with an affinity in the femtomolar
228 del protein, bovine pancreatic ribonuclease (RNase A), decreases upon binding to its cognate inhibito
231 r catalysis of RNA cleavage by ribonuclease (RNase) A can exceed 10(9) M(-1) s(-1) in a solution of l
232 e concentrations of the native ribonuclease (RNase) A protein and RNase B glycoprotein within mixture
234 les (keratin 25, trichohyalin, ribonuclease, RNase A family, 7) and inflammation-related molecules (S
236 s of 1, the folding of reduced and scrambled RNase A at pH 7.0 and 7.7 in the presence of 1 and gluta
239 appeared required for this retention, since RNase A treatment of Triton-permeabilized oocytes or mic
241 cts with chaperone Hsc70 and a CMA substrate RNase A with comparable affinity but not with Hsp40 and
245 ase 4 and RNase 5/ang 1 are unique among the RNase A ribonuclease genes in that they maintain a compl
247 is similar to the activation barrier for the RNase A catalyzed reaction and thus would not be thermod
249 enzyme in which a 6-residue loop 1 from the RNase A homologue, eosinophil cationic protein (ECP), re
251 namically and functionally reproduced in the RNase A scaffold upon creation of a chimeric hybrid betw
253 andard with the target and employment of the RNase A digestion step allow accurate and reproducible q
254 one cleavage-transesterification step of the RNase A enzyme remains controversial even after 60 years
256 icate a 4-fold higher binding ability of the RNase A immobilized with a preferred orientation over RN
257 erspective on the molecular evolution of the RNase A superfamily, as well as an impetus for applying
258 giogenin (hANG), an angiogenic member of the RNase A superfamily, have been recently reported in pati
259 (ANG), a 14.2-kDa polypeptide member of the RNase A superfamily, is an angiogenic protein that has b
261 non-vertebrate protein found to possess the RNase A superfamily fold, and homologs of this toxin are
263 This and other evidence suggests that the RNase A superfamily originated from an RNase 5-like gene
269 binding of the product analogue, 3'-CMP, to RNase A(ECP) results in only minor chemical shift change
272 HIV-1 capsids were almost as insensitive to RNase A as GagZip capsids, suggesting that RNA is not a
274 rimetric data show that binding of pTppAp to RNase A is exothermic (DeltaH = -60.1 +/- 4.1 kJ/mol) wi
275 f the ribonuclease inhibitor protein (RI) to RNase A on these surfaces was characterized by using ell
276 e analogues bind more tightly to ANG than to RNase A, and are the first small molecules shown to exhi
278 uction of RI diminishes the potency of toxic RNase A variants, but has no effect on the cytotoxicity
279 stark contrast to dimerization of wild-type RNase A, which requires incubation under extreme conditi
280 ational propensities of reductively unfolded RNase A under folding conditions, since earlier work has
285 ata are consistent with a mechanism in which RNase A associates with RNA in an intermediate complex,
287 me range access, (iii) biocompatibility with RNase A, and (iv) explicit treatment of mixing for impro
288 d to the several hundred-fold decreases with RNase A and Ang, and individual mutations of three other
289 np(0/0) (PrP knockout) brain homogenate with RNase A or micrococcal nuclease inhibited hamster but no
291 s abolished by the incubation of nuclei with RNase A or DNase, indicating that the interaction depend
292 Previous studies on the complexes of RI with RNase A and angiogenin revealed that RI utilises largely
295 Previous oxidative folding results for wt-RNase A indicated the predominance of the des [40-95] in
296 ll with the corresponding distribution in wt-RNase A and with distributions based on calculations of
297 pulation of the [65-72] disulfide bond in wt-RNase A, these results indicate a critical role for the
298 iates of [C65S, C72S] compared to that of wt-RNase A lends support for a physicochemical basis for th
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。